ArticleBone marrow transplantation2010

CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies.

S G Holtan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.